Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jubb

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanomaChristy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Plos One|March 8, 2013
High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neckDavid S Shames, Juliet Carbon, Kim Walter, et al.
Nature|June 2, 1998
Human gene for physical performanceH E Montgomery, R Marshall, H Hemingway, et al.
The Journal of Experimental Medicine|October 30, 2013
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degenerationChristine D Pozniak, Arundhati Sengupta Ghosh, Alvin Gogineni, et al.
Environmental Science. Processes & Impacts|November 20, 2018
Accuracy of methods for reporting inorganic element concentrations and radioactivity in oil and gas wastewaters from the Appalachian Basin, U.S. based on an inter-laboratory comparisonT L Tasker, W D Burgos, M A Ajemigbitse, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
The Journal of Pathology|July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibitionWei Zhou, Adrian M Jubb, Karen Lyle, et al.
The Journal of Clinical Investigation|August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacyLeisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Breast Cancer Research : BCR|April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agentsChristy C Ong, Sarah Gierke, Cameron Pitt, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanomaChristy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Plos One|March 8, 2013
High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neckDavid S Shames, Juliet Carbon, Kim Walter, et al.
Nature|June 2, 1998
Human gene for physical performanceH E Montgomery, R Marshall, H Hemingway, et al.
The Journal of Experimental Medicine|October 30, 2013
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degenerationChristine D Pozniak, Arundhati Sengupta Ghosh, Alvin Gogineni, et al.
Environmental Science. Processes & Impacts|November 20, 2018
Accuracy of methods for reporting inorganic element concentrations and radioactivity in oil and gas wastewaters from the Appalachian Basin, U.S. based on an inter-laboratory comparisonT L Tasker, W D Burgos, M A Ajemigbitse, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
The Journal of Pathology|July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibitionWei Zhou, Adrian M Jubb, Karen Lyle, et al.
The Journal of Clinical Investigation|August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacyLeisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Breast Cancer Research : BCR|April 24, 2015
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agentsChristy C Ong, Sarah Gierke, Cameron Pitt, et al.
Pageof 10